Episode details
Available for over a year
Taken for morning sickness in the late 1950s and early 1960s, Thalidomide caused faults in the development of unborn children. But the drug was not taken out of circulation and this programme is a discussion on the benefits of Thalidomide to to treat leprosy, AIDs, cancer and eye conditions. With Vivien Kerr of the Thalidomide Society, Mark Nelson of the Chelsea and Westminster Hospital and Joanna Horobin of the drug company EntreMed.
Programme Website